Anthralin Cas 1143-38-0

Anthralin (CAS 1143-38-0) Product Guide

Table of Contents

• 1. Product Specifications & Comparative Analysis
• 2. Key Applications & Functional Mechanisms
• 3. Operational Protocols & Best Practices
• 4. Industry Use Cases
• 5. Client Success Stories
• 6. Technical Consultation & Ordering

1. Product Specifications & Comparative Analysis

2. Key Applications & Functional Mechanisms

Primary Uses:

• Psoriasis treatment via keratinocyte apoptosis induction
• Anti-proliferative agent in dermatological research
• Mitochondrial function modulation studies

3. Operational Protocols & Best Practices

Recommended Workflow:

1. Storage: -20°C protected from light
2. Reconstitution: Use anhydrous DMSO (10 mM stock solution)
3. Dosage: 0.1%-3% concentration in topical formulations

4. Industry Use Cases

Scenario 1: Pharmaceutical cream development (0.5% w/w formulation) for plaque psoriasis management

Scenario 2: In vitro study of mitochondrial ROS suppression in keratinocytes

5. Client Success Stories

Case 1: PsorHeal Inc. (USA)

• Application: Development of sustained-release anthralin gel
• Result: 40% improvement in formulation stability vs conventional creams
• Client Feedback: “Reduced R&D cycle time by 3 months”

Case 2: OncoResearch Labs (Germany)

• Application: Investigation of anthralin-induced apoptosis in melanoma cells
• Result: IC50 value of 8.7 μM achieved in B16F10 cell line
• Client Feedback: “Consistent batch-to-batch performance”

6. Technical Consultation & Ordering

Contact our pharmaceutical chemistry experts:

Email: info@vivalr.com
Tel: (86) 15866781826

Order Documentation Available:

• Certificate of Analysis (CoA)
• Material Safety Data Sheet (MSDS)
• GMP Compliance Certification